OC
HQH

Oppenheimer & Co’s abrdn Healthcare Investors HQH Stock Holding History

Oppenheimer & Co’s Portfolio HQH Stock Details HQH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.07M Sell
116,628
-13,489
-10% -$255K 0.03% 581
2025
Q4 		$2.46M Buy
130,117
+5,306
+4% +$100K 0.04% 485
2025
Q3 		$2.3M Sell
124,811
-31,955
-20% -$522K 0.03% 555
2025
Q2 		$2.43M Buy
156,766
+13,765
+10% +$213K 0.03% 515
2025
Q1 		$2.32M Sell
143,001
-31,267
-18% -$537K 0.04% 506
2024
Q4 		$2.8M Buy
174,268
+84,731
+95% +$1.5M 0.04% 458
2024
Q3 		$1.67M Buy
89,537
+19,008
+27% +$354K 0.03% 611
2024
Q2 		$1.23M Sell
70,529
-42,858
-38% -$716K 0.02% 694
2024
Q1 		$1.91M Buy
113,387
+16,318
+17% +$278K 0.03% 532
2023
Q4 		$1.61M Buy
97,069
+14,757
+18% +$227K 0.03% 563
2023
Q3 		$1.28M Buy
82,312
+1,566
+2% +$26.1K 0.03% 590
2023
Q2 		$1.38M Buy
80,746
+4,135
+5% +$71.7K 0.03% 593
2023
Q1 		$1.35M Buy
76,611
+910
+1% +$16.6K 0.03% 575
2022
Q4 		$1.36M Sell
75,701
-670
-0.9% -$12.4K 0.03% 552
2022
Q3 		$1.32M Buy
76,371
+6,696
+10% +$128K 0.03% 561
2022
Q2 		$1.3M Buy
69,675
+1,031
+2% +$20.4K 0.03% 593
2022
Q1 		$1.43M Buy
68,644
+542
+0.8% +$11.5K 0.03% 614
2021
Q4 		$1.62M Buy
68,102
+13,091
+24% +$326K 0.03% 585
2021
Q3 		$1.41M Sell
55,011
-15,241
-22% -$401K 0.03% 618
2021
Q2 		$1.81M Buy
70,252
+1,895
+3% +$46.7K 0.03% 548
2021
Q1 		$1.67M Buy
68,357
+4,432
+7% +$108K 0.03% 522
2020
Q4 		$1.52M Buy
63,925
+5,172
+9% +$112K 0.03% 517
2020
Q3 		$1.21M Sell
58,753
-492
-0.8% -$10.4K 0.03% 520
2020
Q2 		$1.26M Buy
59,245
+12,933
+28% +$264K 0.03% 493
2020
Q1 		$824K Sell
46,312
-1,007
-2% -$19.9K 0.03% 587
2019
Q4 		$988K Buy
47,319
+1,154
+2% +$22.9K 0.02% 630
2019
Q3 		$847K Sell
46,165
-4,698
-9% -$90.6K 0.02% 640
2019
Q2 		$1.02M Buy
50,863
+2,480
+5% +$49K 0.03% 590
2019
Q1 		$994K Buy
48,383
+942
+2% +$19.3K 0.03% 583
2018
Q4 		$852K Buy
47,441
+1,343
+3% +$27.5K 0.03% 567
2018
Q3 		$1.07M Sell
46,098
-1,073
-2% -$24.3K 0.03% 581
2018
Q2 		$1.01M Buy
47,171
+2,626
+6% +$55.9K 0.03% 589
2018
Q1 		$959K Sell
44,545
-893
-2% -$20.6K 0.02% 626
2017
Q4 		$1.02M Sell
45,438
-210
-0.5% -$4.91K 0.03% 605
2017
Q3 		$1.15M Sell
45,648
-379
-0.8% -$9.52K 0.03% 564
2017
Q2 		$1.16M Sell
46,027
-343
-0.7% -$8.5K 0.03% 545
2017
Q1 		$1.11M Sell
46,370
-2,319
-5% -$54.4K 0.03% 539
2016
Q4 		$1.03M Buy
48,689
+270
+0.6% +$6.01K 0.03% 550
2016
Q3 		$1.15M Buy
48,419
+1,601
+3% +$40.3K 0.03% 532
2016
Q2 		$1.1M Buy
46,818
+521
+1% +$12.9K 0.03% 533
2016
Q1 		$1.11M Sell
46,297
-1,156
-2% -$27.5K 0.03% 510
2015
Q4 		$1.41M Sell
47,453
-117
-0.2% -$3.61K 0.04% 449
2015
Q3 		$1.31M Sell
47,570
-530
-1% -$18K 0.04% 488
2015
Q2 		$1.67M Buy
48,100
+4,597
+11% +$160K 0.05% 463
2015
Q1 		$1.48M Buy
43,503
+1,256
+3% +$42.1K 0.04% 507
2014
Q4 		$1.3M Buy
42,247
+10,577
+33% +$318K 0.04% 528
2014
Q3 		$880K Buy
31,670
+415
+1% +$11.2K 0.03% 644
2014
Q2 		$806K Buy
31,255
+6,514
+26% +$170K 0.02% 687
2014
Q1 		$658K Buy
24,741
+631
+3% +$17.5K 0.02% 741
2013
Q4 		$636K Buy
24,110
+2,632
+12% +$64.5K 0.02% 725
2013
Q3 		$504K Buy
21,478
+3,050
+17% +$72.1K 0.02% 759
2013
Q2 		$414K Buy
+18,428
New +$392K 0.02% 790

Other funds holding HQH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Oppenheimer & Co's HQH Position: Q1 2026 in Review

Oppenheimer & Co reduced its abrdn Healthcare Investors (HQH) stake by 10% in Q1 2026, selling an estimated $255K and leaving 116,628 shares worth $2.07M. The position accounts for 0.03% of the portfolio, ranked #581.

Oppenheimer & Co first reported a position in HQH in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.8M in Q4 2024. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.

  • Oppenheimer & Co held 116,628 shares of abrdn Healthcare Investors worth $2.07M as of Q1 2026.
  • Oppenheimer & Co sold 13,489 abrdn Healthcare Investors shares in Q1 2026, an estimated $255K.
  • abrdn Healthcare Investors made up 0.03% of Oppenheimer & Co's portfolio in Q1 2026, its #581 holding.
  • Oppenheimer & Co first reported a position in abrdn Healthcare Investors in Q2 2013 and has held it in 52 quarters since.
  • Oppenheimer & Co's abrdn Healthcare Investors position peaked at $2.8M in Q4 2024.
  • 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.